Literature DB >> 24090607

Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL.

Josien van Es1, Paul L den Exter, Ad A Kaptein, Cornelie D Andela, Petra M G Erkens, Frederikus A Klok, Renee A Douma, Inge C M Mos, Danny M Cohn, Pieter W Kamphuisen, Menno V Huisman, Saskia Middeldorp.   

Abstract

INTRODUCTION: Although quality of life (QoL) is recognized as an important indicator of the course of a disease, it has rarely been addressed in studies evaluating the outcome of care for patients with pulmonary embolism (PE). This study primarily aimed to evaluate the QoL of patients with acute PE in comparison to population norms and to patients with other cardiopulmonary diseases, using a generic QoL questionnaire. Secondary, the impact of time period from diagnosis and clinical patient characteristics on QoL was assessed, using a disease-specific questionnaire.
METHODS: QoL was assessed in 109 consecutive out-patients with a history of objectively confirmed acute PE (mean age 60.4 ± 15.0 years, 56 females), using the generic Short Form-36 (SF-36) and the disease specific Pulmonary Embolism Quality of Life questionnaire (PEmb-QoL). The score of the SF-36 were compared with scores of the general Dutch population and reference populations with chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), a history of acute myocardial infarction (AMI), derived from the literature. Scores on the SF-35 and PEmb-QoL were used to evaluate QoL in the short-term and long-term clinical course of patients with acute PE. In addition, we examined correlations between PEmb-QoL scores and clinical patient characteristics.
RESULTS: Compared to scores of the general Dutch population, scores of PE patients were worse on several subscales of the SF-36 (social functioning, role emotional, general health (P<0.001), role physical and vitality (P<0.05)). Compared to patients with COPD and CHF, patients with PE scored higher (=better) on all subscales of the SF-36 (P ≤ 0.004) and had scores comparable with patients with AMI the previous year. Comparing intermediately assessed QoL with QoL assessed in long-term follow-up, PE patients scored worse on SF-36 subscales: physical functioning, social functioning, vitality (P<0.05), and on the PEmb-QoL subscales: emotional complaints and limitations in ADL (P ≤ 0.03). Clinical characteristics did not correlate with QoL as measured by PEmb-QoL.
CONCLUSION: Our study demonstrated an impaired QoL in patients after treatment of PE. The results of this study provided more knowledge about QoL in patients treated for PE.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  ADL; AMI; BMI; CHF; COPD; CTEPH; IQR; LMWH; PE; PEmb-QoL; Pulmonary Embolism Quality of Life; Pulmonary embolism; Qanadli score; QoL; Quality of life; SD; SE; SF-36; Short Form-36; VTE; Venous thrombo-embolism; activities of daily living; acute myocardial infarction; body mass index; chronic obstructive pulmonary disease; chronic thromboembolic pulmonary hypertension; congestive heart failure; interquartile range; low molecular weight heparin; pulmonary embolism; quality of life; standard deviation; standard error; venous thromboembolism

Mesh:

Year:  2013        PMID: 24090607     DOI: 10.1016/j.thromres.2013.06.016

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  21 in total

1.  Reduction in physical function in women after venous thromboembolism.

Authors:  K A Hagan; L B Harrington; J Kim; O Zeleznik; E B Rimm; F Grodstein; C Kabrhel
Journal:  J Thromb Haemost       Date:  2018-06-08       Impact factor: 5.824

2.  Quality of life after pulmonary embolism: first cross-cultural evaluation of the pulmonary embolism quality-of-life (PEmb-QoL) questionnaire in a Norwegian cohort.

Authors:  Mazdak Tavoly; Lars-Petter Jelsness-Jørgensen; Hilde Skuterud Wik; Christina Roaldsnes; Per Morten Sandset; Waleed Ghanima
Journal:  Qual Life Res       Date:  2014-08-14       Impact factor: 4.147

3.  Different strategies for pharmacological thromboprophylaxis for lower-limb immobilisation after injury: systematic review and economic evaluation.

Authors:  Abdullah Pandor; Daniel Horner; Sarah Davis; Steve Goodacre; John W Stevens; Mark Clowes; Beverley J Hunt; Tim Nokes; Jonathan Keenan; Kerstin de Wit
Journal:  Health Technol Assess       Date:  2019-12       Impact factor: 4.014

4.  Reliability and validity of the Chinese version of the questionnaire of olfactory disorders (QOD) when used with patients having olfactory dysfunction.

Authors:  DaHai Yang; Jian Wang; DaoFeng Ni; JianFeng Liu; Xin Wang
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-01-02       Impact factor: 2.503

5.  Contribution of fibrinolysis to the physical component summary of the SF-36 after acute submassive pulmonary embolism.

Authors:  Lauren K Stewart; Geoffrey W Peitz; Kristen E Nordenholz; D Mark Courtney; Christopher Kabrhel; Alan E Jones; Matthew T Rondina; Deborah B Diercks; James R Klinger; Jeffrey A Kline
Journal:  J Thromb Thrombolysis       Date:  2015-08       Impact factor: 2.300

6.  Randomized trial of inhaled nitric oxide to treat acute pulmonary embolism: The iNOPE trial.

Authors:  Jeffrey A Kline; Cassandra L Hall; Alan E Jones; Michael A Puskarich; Ronald A Mastouri; Tim Lahm
Journal:  Am Heart J       Date:  2017-01-27       Impact factor: 4.749

7.  Prevention and management of venous thromboembolism in pregnancy: cutting through the practice variation.

Authors:  Leslie Skeith
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

8.  Effect of metabolic syndrome on mean pulmonary arterial pressures in patients with acute pulmonary embolism treated with catheter-directed thrombolysis.

Authors:  Lauren K Stewart; Daren M Beam; Thomas Casciani; Scott J Cameron; Jeffrey A Kline
Journal:  Int J Cardiol       Date:  2019-12-26       Impact factor: 4.164

9.  A Qualitative Study to Appraise Patients and Family Members Perceptions, Knowledge, and Attitudes towards Venous Thromboembolism Risk.

Authors:  Claudie Haxaire; Cécile Tromeur; Francis Couturaud; Christophe Leroyer
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

10.  Quality of life in patients with pulmonary embolism treated with edoxaban versus warfarin.

Authors:  Roisin Bavalia; Ingrid M Bistervels; Wim G Boersma; Isabelle Quere; Dominique Brisot; Nicolas Falvo; Dominique Stephan; Francis Couturaud; Sebastian Schellong; Jan Beyer-Westendorf; Karine Montaclair; Waleed Ghanima; Marije Ten Wolde; Michiel Coppens; Emile Ferrari; Olivier Sanchez; Patrick Carroll; Pierre-Marie Roy; Susan R Kahn; Karina Meijer; Simone Birocchi; Michael J Kovacs; Amanda Hugman; Hugo Ten Cate; Hilde Wik; Gilles Pernod; Marie-Antoinette Sevestre-Pietri; Michael A Grosso; Minggao Shi; Yong Lin; Barbara A Hutten; Peter Verhamme; Saskia Middeldorp
Journal:  Res Pract Thromb Haemost       Date:  2021-07-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.